Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JUNE 05, 2016 FBO #5308
SOLICITATION NOTICE

R -- Global and country-specific rates and trends in incidence of diagnosed type 2 diabetes

Notice Date
6/3/2016
 
Notice Type
Presolicitation
 
NAICS
541611 — Administrative Management and General Management Consulting Services
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2016-Q-65242
 
Archive Date
12/3/2016
 
Point of Contact
Timothy Barnes, Phone: 7704882883
 
E-Mail Address
krz3@cdc.gov
(krz3@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a notice of intent to sole source. The Centers for Disease Control and Prevention (CDC) 2920 Brandywine Road, Atlanta, GA 30341 intends to sole source, in accordance with FAR Part 13.106-1(b)(1) for statistical assembly and analysis of data on type 2 diabetes incidence collected or reported by various countries. The CDC intent is to sole source the following requirement to Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, 3004, Victoria, Australia. The North American Industry Classification System code is 541611. To date, no systematic reviews have reported on trends in global diabetes incidence and data from country-level registries have not been assembled or compared. However, beginning in 2015 through their work with the International Diabetes Federation's Diabetes Atlas, investigators from the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, began to assemble non-published data on diabetes incidence from unpublished registries. The combination of this data with a contemporary systematic review of recently published reports on diabetes incidence trends presents an important opportunity for CDC to increase its knowledge base on the epidemiology of diabetes. Baker ISI is the only group to date that has established international collaboration agreements from large administrative data sources in 12 different countries to extract data on diabetes incidence rate. The group has extensive knowledge and expertise in the coordination, acquisition and analysis of regional and country-level data on diabetes incidence. Specific objectives of this work are to: 1. Assess global, region, and country-specific rates and trends in incidence of diagnosed type 2 diabetes. 2. Assess variation and population sub-group differences in diagnosed type 2 diabetes. 3. Identify international data gaps and methodological deficiencies in the surveillance and monitoring of diagnosed diabetes. 4. Establish a baseline, methodological framework, precedent, and guidance/recommendations for continued international monitoring of incidence of diagnosed diabetes This notice of intent is not a request for competitive quotes. No solicitation document is available and telephone requests will not be accepted. However, any firm that believes it can meet the requirements may give written notification to the Contract Specialist on or before 3:00 pm EST on June 18, 2016. Supporting evidence must be furnished in sufficient detail, to demonstrate the ability to comply with the above requirements. All vendors/prospective contractors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. All questions must be in writing and must be emailed to Tim Barnes at krz3@cdc.gov. Please reference CDC-2016-Q-65242 on all correspondence. Responses received will be considered for future procurements. A determination by the Government not to compete the proposed procurement is solely within the discretion of the Government. If no responses are received, the CDC will proceed to sole source this requirement to Baker IDI Heart and Diabetes Institute. The anticipated period of performance is from September 1, 2016 to February 28, 2018.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-Q-65242 /listing.html)
 
Place of Performance
Address: 75 Commercial Road, Melbourne, 3004, Victoria, Australia., Victoria, Australia
 
Record
SN04138342-W 20160605/160603234749-8c4652797ee5f3af3b1241d4d252e12e (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.